Why now is the time for investors to go for gold

March 14, 2019

Gold is trending again … but is it a traditional reaction to increased market uncertainty or is it a sign of a brighter long-term future for the yellow metal?


Is cannabis Big Pharma’s latest drug?

March 14, 2019

With the medical marijuana market expected to hit US$ 40 billion by 2024, and the potential for cannabis compounds to displace opiates, traditional drugmakers are betting big on weed


Daniel Straus discusses Horizons Seasonal Rotation ETF

March 12, 2019

Daniel Straus, head of ETF research and strategy at National Bank Financial, discusses Horizons Seasonal Rotation ETF.


Horizons ETFs Management (TSE:HMMJ) SVP on Recreational Cannabis Revenue Trajectory

February 27, 2019

Horizons ETFs Management (TSE:HMMJ) (OTCMKTS:HMLSF) SVP Mark Noble likes the trajectory of recent financial reporting in the Canadian cannabis space. Noble believes earnings are moving in the right direction because the reporting shows investors adult use cannabis sales are real and that companies are meeting targets.


Higher nat gas and oil prices ahead: Horizons ETF's Brooke Thackray

February 26, 2019

Brooke Thackray, research analyst at Horizons ETF Management, explains why he sees higher prices ahead for oil and natural gas, including gas inventories in the U.S. that are well below their five-year averages.


Expect This to Become the Newest Pot Stock Trend in 2019

February 25, 2019

Unlike most marijuana stock trends, investors may not be too happy about this one.


Mark Noble Discusses Farm Bill’s Impact on TSX-Listed Companies

February 13, 2019

Horizons ETFs Management Senior Vice President Mark Noble addresses the impact of the Farm Bill’s passage on TSX-listed companies.


Preferred-share ETFs come with risk

February 12, 2019

Often considered a conservative investment, preferreds remain subject to equity market movements


'Shareholders are frustrated': Aphria investors divided on Green Growth's hostile bid

February 06, 2019

Some investors are painting the bid as 'undervalued' and 'futile,' while others seem to have lost faith in Aphria’s management and welcome change


Canadian Pot ETF Retakes Billion-Dollar Mark on Stock Surge

February 05, 2019

The New Year’s rally in pot stocks has sent assets in the first marijuana exchange-traded fund back above C$1 billion for the first time since Oct. 18, the day after Canada legalized recreational pot.


Horizons ETFs is a Member of Mirae Asset Global Investments. Commissions, management fees and expenses all may be associated with an investment in exchange traded products managed by Horizons ETFs Management (Canada) Inc. (the "Horizons Exchange Traded Products"). The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.

The Horizons Exchange Traded Products include our BetaPro Products which consist of our 2x Daily Bull and 2x Daily Bear ETFs ("2x Daily ETFs"), Inverse ETFs ("Inverse ETFs") and our VIX ETF (defined below). The 2x Daily ETFs and certain other BetaPro Products use leveraged investment techniques that can magnify gains and losses and may result in greater volatility of returns. These BetaPro Products are subject to leverage risk and may be subject to aggressive investment risk and price volatility risk, which, where applicable, are described in their respective prospectuses. Each 2x Daily ETF seeks a return, before fees and expenses, that is either 200% or -200% of the performance of a specified underlying index, commodity or benchmark (the "Target") for a single day. Each Inverse ETF seeks a return that is -100% of the performance of a Target. Due to the compounding of daily returns, a 2x Daily ETF's or Inverse ETF's returns over periods other than one day will likely differ in amount and, for the 2x Daily ETFs, possibly direction from the performance of their respective Target(s) for the same period. The BetaPro Product whose Target is the S&P 500 VIX Short-Term Futures Index™ (the "VIX ETF"), which is a (1x) VIX ETF, as described in the prospectus, is a speculative investment tool that is not a conventional investment. The VIX ETF’s Target is highly volatile. As a result, the VIX ETF is not generally viewed as stand-alone long-term investment. Historically, the VIX ETF’s Target has tended to revert to a historical mean. As a result, the performance of the VIX ETFs' Target is expected to be negative over the longer term and neither the VIX ETF nor its Target is expected to have positive long term performance. Investors should monitor their holdings, as frequently as daily, to ensure that they remain consistent with their investment strategies.

*The indicated rates of return are the historical annual compounded total returns including changes in per unit value and reinvestment of all dividends or distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The rates of return shown in the table are not intended to reflect future values of the ETF or returns on investment in the ETF. Only the returns for periods of one year or greater are annualized returns.